Lipids The Evolving Role of Nonstatin Medication in the Management of Hypercholesterolemia Joseph Saseen, PharmD, CLS Fighting the Ladykiller (and side effects) with Cholesterol Lowering Therapy Margo B. Minissian, PhD, ACNP Should We Measure Lipoprotein(a) and What Should We Do With the Results? Samia Mora, MD, MHS « Page 1 » CME Webcasts Racial/Ethnic Disparities in Cardiovascular Outcomes The Evolving Role of Nonstatin Medication in the Management of Hypercholesterolemia Sleep Health: Healthy Sleep, Healthy Heart The Impact of Periodontal Disease on Metabolic and Cardiovascular Disease Fighting the Ladykiller (and side effects) with Cholesterol Lowering Therapy News You Can Use Currently Recommended Risk Models Fail to Identify Heart Risk in Patients with Rheumatoid Arthritis Nonobstructive CAD, Women, and Prevention of Cardiovascular Events Is Now the Time to Target Both LDL and Inflammation? Inflammatory Markers and Adiponectin Help Define Risk – Looking Beyond Traditional Risk Factors Elevated Urinary Microalbumin Creatine Ratio Associated with Worse Outcomes
